STUDY OF EPIDEMIOLOGY AND ITS PROGNOSTIC FACTORS FOR EXPECTED THERAPEUTIC MANAGEMENT OUTCOME ALONG WITH THE ANTIHYPERTENSIVE DRUG PATTERN FOR PREECLAMPSIA IN RURAL SETTING
Abstract
This study analyses the association between epidemiological factors and preeclampsia and the antihypertensive drug pattern used at different stages of preeclampsia. Total 252 patients were enrolled for study. Some of the study variables which were studied was maternal age, history of infertility, family income, education, antihypertensive drug used, body mass index of mother and baby’s birth weight. Study was performed SGT Hospital, Gurugram and was given ethical clearance by the Institutional Ethical Committee (IEC). Data was collected with the help of validated questionnaires. Occurrence of Pregnancy Induced Hypertension (PIH) in our study was found to be 47.2%. Maternal age, low socioeconomic status, less education level, >36 weeks of gestation are one of some major factors responsible for PIH. The current study implies that different dosage forms of labetalol was prescribed with P value <0.05.
Keywords:
PIH, Epidemiology, Ritors, Antihypertensive DrugsDOI
https://doi.org/10.25004/IJPSDR.2023.150409References
Kumari Shekhawat S, Choudhary V, Shekhawat U. Co-Relation Of Fundus Changes & Pregnancy Induced Hypertension-A Prospective Observational Study. IOSR J Dent Med Sci. 2019; 18: 46–54.
K. DRK, Nayak DSR. Preeclampsia/Eclampsia and Retinal Micro Vascular Characteristics Affecting Maternal and Foetal Outcome: A Prospective Study amongst South Indian Pregnant Women. Int J Innov Res Dev. https://www.internationaljournalcorner.com/
index.php/ijird_ojs/article/view/134039 (2013, accessed 4 July2023).
Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening. BMJ. 2002; 325: 157–160.
Callaway LK, Mamun A, McIntyre HD, et al. Does a history of hypertensive disorders of pregnancy help predict future essential hypertension? Findings from a prospective pregnancy cohort study. J Hum Hypertens. 2012; 27: 309–314.
Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ Br Med J. 2007; 335: 974.
Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ Br Med J. 2003; 326: 845.
Wiles K, Damodaram M, Frise C. Severe hypertension in pregnancy. Clin Med (Northfield Il). 2021; 21: e451–e456.
Green LJ, Mackillop LH, Salvi D, et al. Gestation-Specific Vital Sign Reference Ranges in Pregnancy. Obstet Gynecol. 2020; 135:653–664.
Dadelszen P Von DA. Classification of the hyper tensive disorders of pregnancy. researchgate.net, https://www.researchgate.net/profile/Dr-Hoodbhoy/publication/312916347_
T he _ F IGO_Te x t book _ of _ P r e g na nc y_Hy pe r t en s i o n/
links/5889b3efa6fdcc9a35c35ee1/The-FIGO-Textbook-of-
Pregnancy-Hypertension.pdf#page=51 (2016, accessed 17 January
.
Achamrah N, Ditisheim A. Nutritional approach to preeclampsia prevention. Curr Opin Clin Nutr Metab Care. 2018; 21: 168–173.
Goel A, Maski MR, Bajracharya S, et al. Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period. Circulation. 2015; 132: 1726–1733.
American College of Obstetricians, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122: 1122–1131.
Coutinho T, Lamai O, Nerenberg K. Hypertensive Disorders of Pregnancy and Cardiovascular Diseases: Current Knowledge and Future Directions. Curr Treat Options Cardiovasc Med. 20. Epub ahead of print 1 July 2018. DOI: 10.1007/S11936-018-0653-8.
Tooher J, Thornton C, Makris A, et al. All hypertensive disorders of pregnancy increase the risk of future cardiovascular disease. Hypertension. 2017; 70: 798–803.
Magee LA, Nicolaides KH, Von Dadelszen P. Preeclampsia. Obstet Gynecol Surv. 2022; 77: 641–643.
Gangadhar L, Rengaraj S, Thiyagalingam S, et al. Maternal and perinatal outcome of women with early-onset severe pre-eclampsia before 28 weeks: Is expectant management beneficial in a lowresource country? A prospective observational study. Int J Gynecol
Obstet. 2023; 161: 1075–1082.
Malik A, Jee B, Gupta SK. Preeclampsia: Disease biology and burden, its management strategies with reference to India. Pregnancy Hypertens. 2019; 15: 23–31.
Drechsel KCE, Adu-Bonsaffoh K, Olde Loohuis KM, et al. Maternal near-miss and mortality associated with hypertensive disorders of pregnancy remote from term: a multicenter observational study in Ghana. AJOG Glob Reports. 2022; 2: 100045.
Mazda Y, Tanaka M, Terui K, et al. Postoperative renal function in parturients with severe preeclampsia who underwent caesarean delivery: a retrospective observational study. J Anesth. 2018; 32:447–451.
Sarkar S. Prevalence and determinants of the use of caesarean section (CS) in the dichotomy of ‘public’ and ‘private’ health facilities in West Bengal. India. Clin Epidemiol Glob Heal. 2020; 8: 1377–1383.
Bilano VL, Ota E, Ganchimeg T, et al. Risk Factors of Pre-Eclampsia/Eclampsia and Its Adverse Outcomes in Low- and Middle-Income Countries: A WHO Secondary Analysis. PLoS One. 2014; 9: e91198.
Quaresima P, Visconti F, Interlandi F, et al. Awareness of gestational diabetes mellitus foetal-maternal risks: an Italian cohort study on pregnant women. BMC Pregnancy Childbirth. 2021; 21: 1–8.
Bayrampour H, Heaman M, Duncan KA, et al. Advanced maternal age and risk perception: A qualitative study. BMC Pregnancy Childbirth. 2012; 12: 1–13.
Conde-Agudelo A, Belizán JM. Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. BJOG An Int J Obstet Gynaecol. 2000; 107: 75–83.
Aksornphusitaphong A, Phupong V. Risk factors of early and late onset pre-eclampsia. J Obstet Gynaecol Res. 2013; 39: 627–631.
Lee CJ, Hsieh TT, Chiu TH, et al. Risk factors for pre-eclampsia in an Asian population. Int J Gynecol Obstet. 2000; 70: 327–333.
Qiu C, Williams MA, Leisenring WM, et al. Family history of hypertension and type 2 diabetes in relation to preeclampsia risk. Hypertension. 2003; 41: 408–413.
Roes EM, Sieben R, Raijmakers MTM, et al. Severe Preeclampsia is Associated with a Positive Family History of Hypertension and Hypercholesterolemia. Hypertens Pregnancy. 2009; 24: 259–271. Available from: http://dx.doi.org/101080/10641950500281076.
Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet. 2006; 368: 1164–1170.
[Hypertensive Pregnancy Complicat ions and Eclampsia] Hypertensive svangerskapskomplikasjoner og eklampsi, https://www.legeforeningen.no/foreningsledd/fagmed/norskgynekologisk-forening/veiledere/veileder-i-fodselshjelp/hypertensive-svangerskapskomplikasjoner-og-eklampsi/(accessed 4 July 2023).
Sripad P, Kirk K, Adoyi G, et al. Exploring survivor perceptions of pre-eclampsia and eclampsia in Nigeria through the health belief model. BMC Pregnancy Childbirth. 2019; 19: 1–11.
Nanjundan P, Bagga R, Kalra JK, et al. Risk factors for early onset severe pre-eclampsia and eclampsia among north Indian women. J Obstet Gynaecol. 2011; 31: 384–389. Available from: https://doi.org/103109/014436152011566389.
Wadhwani P, Saha PK, Kalra JK, et al. A study to compare maternal and perinatal outcome in early vs. late onset preeclampsia. Obstet Gynecol Sci. 2020; 63: 270.
Published
Abstract Display: 393 
PDF Downloads: 373 
